New aspects of infective endocarditis

Minerva Cardioangiologica

Volumn 52, Issue 4, 2004, Pages 273-286

  Horstkotte, D ^a   Piper, C ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Echocardiography, transesophageal; Endocarditis, diagnosis; Endocarditis, therapy

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; AZLOCILLIN; CEFOTAXIME; DICLOXACILLIN; FLUCLOXACILLIN; FLUCYTOSINE; GENTAMICIN; MEZLOCILLIN; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; RIFAMPICIN; TOBRAMYCIN; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ALGORITHM; ANAEROBIC BACTERIUM; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL ENDOCARDITIS; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BLOOD BRAIN BARRIER; BRAIN HEMORRHAGE; CHLAMYDIA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DISEASE PREDISPOSITION; DRUG MONITORING; EMBOLISM; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HEART FAILURE; HEART SURGERY; HEART VALVE PROSTHESIS; HEMOPERICARDIUM; HUMAN; INCIDENCE; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; MITRAL VALVE REGURGITATION; MYCOBACTERIUM; PENICILLIN ALLERGY; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PROGNOSIS; REVIEW; RICKETTSIA; SEPSIS; SERODIAGNOSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

AMINOGLYCOSIDES; AMPHOTERICIN B; ANTIFUNGAL AGENTS; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ENDOCARDITIS, BACTERIAL; FLUCYTOSINE; HUMANS; PENICILLINS; PROGNOSIS; VANCOMYCIN;

EID: 4744367895     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Horstkotte D, Follath F, Gutschik E, Lengyel M, Oto A. Pavie A et al. on behalf of the Task Force on Infective Endocarditis of the European Society of Cardiology. Guidelines on prevention, diagnosis and treatment of infective endocarditis: Full Text. www.escardio.org
2. Horstkotte D. Mikrobiell verursachte Endokarditis. Darmstadt: Steinkopff; 1995.
3. Horstkotte D, Piper C. Endocarditis. In: Acar J, Bodnar E. editors. Textbook of acquired heart valve disease. London: ICR; 1995. Vol. II. p. 596-677.
4. McKinsey DS, Rutts TE, Bisno AL. Underlying cardiac lesions in adults with infective endocarditis. The changing spectrum. Am J Med 1987;82:681-7.
5. Leonard A, Raij L, Shapiro FE. Bacterial endocarditis in regularly dialyzed patients. Kidney Int 1973;4:407-22.
6. Mills J, Utlay J, Abbott J. Heart failure in infective endocarditis: predisposing factors, course and treatment. Chest 1974;66:151-9.
7. Kan MN, Chen YT, Lee AYS. Comparison of transesophageal to transthoracic color Doppler echocardiography in the identification of intracardiac mycotic aneurysms in infective endocarditis. Echocardiography 1991;8:643-8
8. Horstkotte D, Piper C, Wiemer M, Schultheiß HP. ZNS-Beteiligung bei akuter Endokarditis. In: Prange H, Bitsch A, editors. Baterielle ZNS-Erkrankungen bei systemischen Infektionen. Darmstadt: Steinkopff; 1998. p.45-63.
9. Kitts D, Bongard FS, Klein SR. Septic embolism complicating infective endocarditis. J Vasc Surg 1991;14:480-7.
10. Neugarten J, Gallo GR, Baldwin DS. Glomerulonephritis in bacterial endocarditis. Am J Kidney Dis 1984;3:371-9.
11. Gutman RA, Striker GE, Gillifond BC, Cutler RE. The immune complex glomerulonephritis of bacterial endocarditis. Medicine 1978;51:1-6.
12. Bennett WM, Muther RS, Parker RA, Feig P, Morrison G, Golper TA et al. Drug therapy in renal failure: dosing guidelines for adults. Part I. Antimicrobial agents, analgesics. Ann Intern Med 1980;93(Part I):62-89.
13. Moore RD, Smith CR, Lipsky JJ, Mellits ED, Lietman PS. Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 1984;100:352-7.
14. Perronne C, Leport C, Vilde J. Complications due to septic embolism and immune-complex vasculitits. In: Horstkotte D, Bodnar E, editors. Infective Endocarditis. London: ICR; 1991. p. 39-43.
15. Piper C, Hetzer R, Körfer R, Bergemann R, Horstkotte D. The importance of seconday mitral valve involvement in primary aortic valve endocarditis: the mitral kissing vegetation. Eur Heart J 2002;23:79-86.
16. Boles JM, Michelet C, Garo B, Garre M, Cartier F. Neurological complications of infective endocarditis. In: Horstkotte D, Bodnar E, editors. Infective endocarditis. London: ICR; 1991. p. 34-8.
17. Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ et al. ACC/AHA guidelines for the clinical application of echocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 1997;95:1686-744.
18. Bayer AS, Bolger AF, Taubert KA, Wilson W, Steckelberg J, Karchmer AW et al. Diagnosis and management of infective endocarditis and its complications. Circulation 1998;98:2936-48.
19. Sochowski RA, Chan KL. Implication of negative results on a monoplane transesophageal echocardiographic study in patients with suspected infective endocarditis. J Am Coll Cardiol 1993;21:216-21.
20. Vuille C, Nidorf M, Weyman AE, Picard MH. Natural history of vegetations during successful medical treatment of endocarditis. Am Heart J 1994;128:1200-9.
21. Gueret P, Vignon P, Fournier P, Chabernaud JM, Gomez M, LaCroix P et al. Transesophageal echocardiography for the diagnosis and management of nonobstructive thrombosis of mechanical mitral valve prosthesis. Circulation 1995;91:103-10.
22. Lengyel M. The impact of transesophageal echocardiography on management of prosthetic valve endocarditis: experience of 31 cases and review of the literature. J Heart Valve Dis 1997;6:204-11.
23. San Roman JA, Vilacosta I, Zamorano IL, Almeria C, Sanchez-Harguindey L. Transesophageal echocardiography in right-sided endocarditis. J Am Coll Cardiol 1993;21:1226-30.
24. Winslow T, Foster E, Adams JR, Schiller NB. Pulmonary valve endocarditis: improved diagnosis with biplane transesophageal echocardiography. J Am Soc Echocardiogr 1992;5:206-10.
25. Vilacosta I, Sarriá C, San Román JA, Jimenez J, Castello JA, Iturralde E et al. Usefulness of transesophageal echocardiography for diagnosis of infected transvenous permanent pacemakers. Circulation 1994;89:2684-7
26. Washington JA. Blood cultures: an overview. Eur J Clin Microbiol Infect Dis 1989;8:803-6.
27. Von Reyn CF, Levy BS, Arbeit RD, Friedland G, Crumpacker CS. Infective endocarditis: an analysis based on strict case definitions. Ann Intern Med 1981;94:505-18.
28. Durack DT, Lukes AS, Bright DK, Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994;96:200-9.
29. Hoen B, Selton-Suty C, Lacassin F, Etienne J, Briancon S, Leport C et al. Infective endocarditis in patients with negative blood cultures: analysis of 88 cases from a one-year nationwide survey in France. Clin Infect Dis 1995;20:501-6.
30. Lüthy R. Principles of antimicrobial therapy in infective endocarditis. In: Horstkotte D, Bodnar E, editors. Infective endocarditis. London: ICR; 1991. p. 93-6.
31. Chastre J, Trouillet JL. Early infective endocarditis on prosthetic valves. Eur Heart J 1995:16 Suppl B:32-8.
32. Horstkotte D, Piper C, Niehues R, Wiemer M, Schultheiss HP. Late prosthetic valve endocarditis. Eur Heart J 1995;16 Suppl B:39-47.
33. Schaff H, Carrel T, Steckelberg JM, Grunkemeier GL, Holubkov R. Artifical Valve Endocarditis Reduction Trial (AVERT): protocol of a multicenter randomized trial. J Heart Valve Dis 1999;8:131-9.
34. Piper C, Horstkotte D, Niehues R, Arendt G, Schulte HD, Schultheiß HP. Indikation, Nicht-Kontraindikation zum dringlichen klappenchirurgischen Eingriff nach akuter zerebraler Embolie bei florider Endokarditis. Intensivmedizin und Notfallmedizin 1995;32:471.
35. Daniel WG, Durst UN. Cardiological diagnosis in arterial embolism. Herz 1991;16:405-18.
36. Elebute EA, Stoner HB. The grading of sepsis. Br J Surg 1983;70:29-32.
37. Horstkotte D, Schulte HD, Niehues R, Klein RM, Piper C, Strauer BE. Diagnostic and therapuetic considerations in acute, severe mitral regurgitation: experience in 42 consecutive patients entering the intensive care unit with pulmonary edema. J Heart Valve Dis 1993;2:512-22.
38. Horstkotte D, Bircks W, Loogen F. Infective endocarditis of native and prosthetic valves - the case for prompt surgical intervention? A retrospective analysis of factors affecting survival. Z Kardiol 1986;75 Suppl 2:168-82.
39. Leport C and the Endocarditis Working Group of the International Society of Chemotherapy. Antibiotic prophylaxis for infective endocarditis. Clin Microbiol Infect 1998;4 Suppl 3:S56-61.
40. Piper C, Körfer R, Horstkotte D. Prosthetic valve endocarditis. Heart 2001;85:590-3.
41. Grover FL, Cohen DJ, Oprian C, Henderson WG, Sethi G, Hammermeister KE. Determinants of the occurrence of and of survival from prosthetic valve endocarditis. J Thorac Cardiovasc Surg 1994;108:207-14.
42. Yee Es, Khonsari S. Rightsided infective endocarditis: valvuloplasty, valvectomy or replacement. J Cardiovasc Surg (Torino) 1989;30:744-8.
43. Moon MR, Stinson EB, Miller DC. Surgical treatment of endocarditis. Progr Cardiovasc Dis 1997;40:239-64.
44. Pettersson G, Carbon C and the Endocarditis Working Group of the International Society of Chemotherapy. Recommendations for the surgical treatment of endocarditis. Clin Microbiol Infect 1998;4 Suppl 3:S34-46.
45. Sons H, Dausch W, Kuh JH. Tricuspid valve repair in right-sided endocarditis. J Heart Valve Dis 1997;6:636-41.